Joseph M. Lane, MD, was born in New York City and raised in Great Neck, Long Island. He received his AB degree (Magna Cum Laude) from Columbia College (1961) and his medical degree from Harvard Medical School (1965). General surgical internship and residency were performed at the Hospital of the University of Pennsylvania (1965-67). Dr. Lane performed bone collagen research at the NIDR at NIH (USPHS) from 1967-69 in Bethesda, Maryland, under Karl Piez and Edward Miller. He had a collagen research fellowship under Darwin Prochop at the CCRC University of Pennsylvania (1969-70) and a three-year orthopaedic residency at the Hospital of the University of Pennsylvania during which time he was awarded the Kappa Delta Award (AAOS) for inhibiting scar formation.
Dr. Lane was the Elsee Butz Assistant Professor (Orthopaedics) at the Hospital University of Pennsylvania and Children’s Hospital of Philadelphia (1973-75). He was appointed Assistant Professor and Chief of the Metabolic Bone Disease Service at Hospital for Special Surgery at Cornell Medical School in 1975, ultimately attaining full Professorship, Assistant Dean, Director of Clinical Research, and Medical Director of the Metabolic Bone Disease Service and Osteoporosis Prevention (1976-93, 96—present). He was appointed Chief of the Bone Tumor Service (osteogenic sarcoma, Ewing’s sarcoma) at the Memorial Sloan-Kettering Cancer Center (1976-91) and Senior Attending (1991-93). From 1993-96 he was Professor and Chairman of the Department of Orthopaedic Surgery at UCLA. He is currently the Associate Director of the Orthopaedic Trauma Service at New York-Presbyterian Hospital.
Dr. Lane has published extensively on bone biology, tissue injury and repair, trauma, bone and soft tissue sarcomas (including osteogenic sarcoma and Ewing’s sarcoma), limb preservation, functional amputations, limb regeneration, and metabolic bone diseases (osteoporosis, Paget’s disease, rickets, osteomalacia, fibrous dysplasia).
He has served on numerous committees for the AAOS, including the Board of Directors and Chairman of COMSS, the Chairman Oversight Panel on Women’s Health Issues. He was President of the Orthopaedic Research Society, Musculoskeletal Tumor Society, Chairman of NIH Orthopaedic Study Section, OREF grants review board, ABOS Question Writing Task Force. He is a member of the AAOS, AOA, ABJS, ASBMR, ORS, MSTS, and OTA. He has earned NIH career and R01 grants, OREF grants, and foundation awards. He has been a visiting professor at educational institutes and is on the editorial board of several peer journals.
Attending Orthopaedic Surgeon, Hospital for Special Surgery
Assistant Dean, Hospital for Special Surgery, Weill Cornell Medical College and affiliated hospitals, NYC
Professor of Orthopaedic Surgery, Weill Cornell Medical College
Adjunct Professor, Department of Orthopaedic Surgery, Columbia University, College of Physicians & Surgeons
Chief, Metabolic Bone Disease Service
Attending Orthopaedic Surgeon, Hospital for Special Surgery, NewYork Hospital
Osteoporosis Metabolic Bone
Malignant and benign bone tumors (osteoglenic, Ewing’s, and soft-tissue sarcomas)
Fractures, non-unions, and delayed healing
Metabolic bone disease (osteoporosis, Paget’s disease, rickets, osteomalacia, fibrous dysplasia, melorheostosis)
Geriatric vertebral compression fractures
Geriatric hip fractures
"Best Doctors in New York," New York magazine, 2009
FDA Orthopaedic Panel, 1999—current
New York State Osteoporosis and Education Program (NYSOPEP), 1999
NIH Tissue Engineering Grant Review Panel, 1998—current
NIH Sickle Cell Hip Program—Oversight Committee, 1998—current
NIH Consensus on Total Hip Replacement—Panelist, 1994
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Lane as of February 27, 2014.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
MD, Harvard Medical School, 1965
Hospital of the University of Pennsylvania, Department of General Surgery, Pennsylvania, 1966-67
Hospital of the University of Pennsylvania, Department of Orthopaedic Surgery, Pennsylvania, 1972-73
National Institute of Arthritis and Metabolic Disease, NIH (USPHS), Research Associate
General Clinical Research Center, Collagen Metabolism (Darwin Prochop), Research Associate
National Board of Medical Examiners
American Board of Orthopaedic Surgeons, September 1974
Board Recertification—American Board of Orthopaedic Surgeons, July 1998
For more publications, please see the PubMed listing.